Prof. Si Longlong's team from the Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences constructed a ...

A protein was created where TDP-43 was fused to the SUMO2 protein and these fusion proteins were expressed in cells with or ...

Healthcare stock Theralase Technologies (TSXV:TLT) recently discovered that its lead drug candidate, Ruvidar, has the potential to inhibit deubiquitinating enzymes, which are linked to certain cancers ...

Kangpu Biopharmaceuticals, Ltd. announced today that the Center for Drug Evaluation (CDE) of China's National Medical ...

Has Discovered a New Mechanism of Action in Its War on Cancer; Specifically, Ruvidar's(TM) Ability to Inhibit ...

Tobacco-based products, including e-cigarettes, have gained popularity as perceived safer alternatives to traditional smoking despite their addictive nature. However, emerging evidence shows that ...

Discomfort in the lower gastrointestinal (GI) tract can affect a person's well-being, and it is very common: For instance, about 10% to 15% of Americans suffer from irritable bowel syndrome (IBS), a ...

来自青海大学农林科学院和青海省农业有害生物综合治理重点实验室的研究人员勇挑重担，开展了一项极具价值的研究。他们的研究成果发表在《Scientific Reports》上，为马铃薯抗黑胫病的研究提供了重要的参考依据。

Researchers from Guilin Medical University and collaborators investigated the potential role of ubiquitin-specific protease 4 (USP4) in the occurrence and development of lung adenocarcinoma.

In a study published in Angewandte Chemie International Edition, a research team integrated activity-based protein profiling ...

Researchers at Goethe University, Johannes Gutenberg University Mainz and Kiel University discover possible method for preventing protein aggregates – Cluster4Future PROXIDRUGS research project.